CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Eyepoint Pharmaceuticals

For profit

Also known as: Eye Point Pharmaceuticals | EyePoint Pharmaceuticals, Inc. | EYEPOINT PHARMS | pSivida Corp. | pSiVida Limited

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jan 1, 2008

First marketed drug

Feb 9, 2018

Last known activity

Dec 31, 2024

Timeline

1980s

  1. Jun 1, 1987

    Eyepoint Pharmaceuticals— Founded

2010s

  1. Feb 9, 2018

    urea— NDA Secondary Org

  2. Feb 9, 2018

    dexamethasone— Marketing Organization

  3. Mar 28, 2018

    Icon Bioscience— Acquired

Drugs by trial phase (6 distinct, 17 trials)

Phase 4 (3 own, 1 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (17)

Details

Founded
Watertown, MA, US Jun 1, 1987
Last known activity
Dec 31, 2024